PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

39,980 stories, page 357 of 667

Advanced search
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Non-animal Testing of Heated Hair Products

Fraunhofer Life SciencesOriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Fraunhofer IPMS Appoints Wenke Weinreich as Second Director

Fraunhofer Life SciencesOriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Energy-Efficient Electric Drying With Superheated Steam

Fraunhofer Life SciencesOriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

When the Fake Boss Calls: A Real-Time Warning System for Fake Videoconferences

Fraunhofer Life SciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Restrictions on Compounding Popular Weight Loss Medications *xNBkPxpOl*

FC BayernOriginal source
🇺🇰Researchmft.nhs.ukTier 2 · Direct publisher

Working towards the NHS net zero target by reducing “gas and air” waste

Manchester University NHS Foundation TrustOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maritide Weight Loss: What the Latest Phase 2 Data Means for Long-Term Management *K3K37KO9J*

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pfizer Weight Loss Drug: Practical Insights on This New Option - View GOJdJ7h0v

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Depo Provera Lawsuit Settlement | August 2026 Litigation Update

Lawsuit Information CenterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Two biotech names on Josh Brown's Best Stocks list are making meaningful highs this summer

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca PLC Stock (AZN) Moved Down by 8.54% on Aug 3: Key Drivers Unveiled

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NICE recommends heart drug aficamten with simultaneous MHRA approval

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Digital systems in general practice could reduce medication errors

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Grants Breakthrough Status to Lilly Pancreatic Cancer Drug

asatunews.co.idOriginal source
🌍Associationnephsap.orgTier 3 · Secondary coverage

New nephSAP Issue: Acute Kidney Injury and Critical Care Nephrology

American Society of NephrologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ceruvia Raises $8 Million to Advance Phase 1/2 Trial of Cluster Headache Therapy

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Weight Loss Drug FDA Approval: What It Means for Your Health Journey in 2026 *fpjJUImpo*

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Latigo, BlossomHill launch US IPOs as biotech listings rebound

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Form 424B5 Moleculin Biotech Inc For: 3 August By Investing.com

Investing.com CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FAQ: Pharma's July 31 Tariff Deadline Has Passed. Now What?

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ERA Pooling Project to support compliance with new environmental requirements

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ceruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache

PA MediaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Spring House Biotech ChromaTan Chases $10M Round After 15 Years

MONTCO.TodayOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Work ethic becomes a flashpoint as China’s biotech pace quickens

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Altimmune (ALT) Begins Enrollment in Phase 3 Trial Amid High Pri

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Is Krystal Biotech (KRYS) Dropping 7.0%?

AlphaStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DOJ Reclassifies Medical Marijuana as Schedule III: What Employers and Businesses Need to Know

jdp.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret

Applied Clinical Trials OnlineOriginal source
🌍Industrysignanthealth.comTier 1 · Company source

Signant Health Launches Forecasting & Planning Assist™

Signant HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Zacks Investment ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Canada Authorizes First Generic Weight-Loss Drug Impacting Pharmaceutical Stocks *3yOXwZZFr*

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Acurx receives FDA guidance on single Phase 3 trial pathway

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Graham Heap Joins cAMPfield as R&D President to Advance Prifemilast Phase 2 Program

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioTech Peach Yogurt Whey and Dragon Fruit Lychee Creatine

stack3d.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Is there a pharma mega-merger in the making?

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Organizational Readiness Pharma's Real AI Barrier in 2026?

PharmTech.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BlossomHill eyes $112M IPO harvest to fund Tagrisso challenger

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech giant Amgen says patient data stolen from third-party cloud systems

The Record from Recorded Future NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sino Biological launches precisely characterised full-length p-Tau217 protein

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ACV Keto Gummies FDA Approved: Your Practical Guide to Apple Cider Vinegar Supplements *ePBM5upFp*

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Two Biotech IPOs Test The Market’s Reopening

FinimizeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Effort to Recall Tavneos Challenged by Drug Maker

AboutLawsuits.comOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

CodexisOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML

The Indian PractitionerOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech Announces Final Dose in Phase 2 DURIPANC Trial Ahead of Schedule for Ampligen in Metastatic Pancreatic Cancer

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veru Inc. Announces August 10, 2026 Conference Call to Discuss Fiscal Third Quarter Results and Business Update

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th

The Manila TimesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Releases Q2 2026 Financial Results

AlphaStreetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China biotech giant WuXi AppTec sees first-half earnings surge amid US scrutiny

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Intelligent Bio Solutions drug screen tested against hand creams and dirt

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CAD-1005 Phase 2 Data Show >25% Absolute Reduction in Thrombotic Events

stocktitan.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

GlobeNewswireOriginal source